Literature DB >> 25912994

Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome.

Elisabeth M Hodson1, Deirdre Hahn, Jonathan C Craig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25912994     DOI： 10.1007/s00467-015-3106-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  14 in total

1.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

2.  Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.

Authors:  Aditi Sinha; Abhijeet Saha; Manish Kumar; Sonia Sharma; Kamran Afzal; Amarjeet Mehta; Mani Kalaivani; Pankaj Hari; Arvind Bagga
Journal:  Kidney Int       Date:  2014-07-16       Impact factor: 10.612

3.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

Review 4.  Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Authors:  Rebecca M Lombel; Debbie S Gipson; Elisabeth M Hodson
Journal:  Pediatr Nephrol       Date:  2012-10-03       Impact factor: 3.714

5.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

6.  Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

7.  Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.

Authors:  Nynke Teeninga; Joana E Kist-van Holthe; Nienske van Rijswijk; Nienke I de Mos; Wim C J Hop; Jack F M Wetzels; Albert J van der Heijden; Jeroen Nauta
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

8.  Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.

Authors:  A Bagga; P Hari; R N Srivastava
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

9.  A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.

Authors:  Masahiro Hiraoka; Hirokazu Tsukahara; Kousaku Matsubara; Masahito Tsurusawa; Nobuaki Takeda; Shinichi Haruki; Shuhei Hayashi; Kazuhide Ohta; Tohru Momoi; Yusei Ohshima; Narufumi Suganuma; Mitsufumi Mayumi
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

Review 10.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  E M Hodson; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  5 in total

Review 1.  How randomised trials have improved the care of children with kidney disease.

Authors:  Elisabeth M Hodson; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2016-08-03       Impact factor: 3.714

2.  Treatment-Associated Side Effects in Patients with Steroid-Dependent Nephrotic Syndrome.

Authors:  Anca Croitoru; Mihaela Balgradean
Journal:  Maedica (Bucur)       Date:  2022-06

3.  Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study.

Authors:  Aishvarya Upadhyay; Om P Mishra; Rajniti Prasad; Shashi K Upadhyay; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2015-09-28       Impact factor: 3.714

Review 4.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

Review 5.  Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association.

Authors:  Manuel Alfredo Podestà; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.